1. K. V. Derkach, E. A. Shpakova, O. A. Zharova, et al., “Effects of immunization of rats with BSA-conjugated peptide 269–280 of the type 3 melanocortin receptor on metabolic measures and thyroid function,” Tsitologiya, 56, No. 11, 850–857 (2014).
2. K. V. Derkach, E. A. Shpakova, O. A. Zharova, and A. O. Shpakov, “Metabolic changes in rats immunized with a BSA conjugate of a peptide derived from the N-terminal part of the type 4 melanocortin receptor,” Dokl. Akad. Nauk., 458, No. 1, 102–105 (2014).
3. A. O. Shpakov, “The role of impairments to the hormonal signal systems in the etiology and pathogenesis of diabetes mellitus,” Zh. Evolyuts. Biokhim. Fiziol., 50, No. 6, 482–486 (2014).
4. A. O. Shpakov and K. V. Derkach, “The peptidergic signal systems of the brain in diabetes mellitus,” Tsitologiya, 54, No. 10, 733–741 (2012).
5. A. O. Shpakov, K. V. Derkach, O. A. Zharova, and E. A. Shpakova, “Functional activity of the adenylate cyclase system in the brains of rats with metabolic syndrome evoked by immunization with peptide 11–25 of the type 4 melanocortin receptor,” Neirokhimiya, 32, No. 1, 37–47 (2015).